Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 1 | FDP00017 | IM / LA |
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs or reactions reported.
None reported
HIV disease Methamphetamine use disorder, severe, in sustained remission (HCC) Abnormal Pap smear of anus Hemorrhoids PTSD (post-traumatic stress disorder) Herpes Allergic rhinitis High risk sexual behavior CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min Transaminitis Fatty liver disease, nonalcoholic HLD (hyperlipidemia) BMI 30.0-30.9,adult Abdominal obesity Tobacco user Research study patient Schizoaffective disorder, depressive type History of hemorrhoids History of constipation Prediabetes The diet is high in sugar History of syphilis
sertraline (ZOLOFT) 100 mg tablet atorvastatin (LIPITOR) 40 mg tab bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25 mg tab Cholecalciferol, Vitamin D3, 125 mcg (5,000 unit) capsule loratadine (CLARITIN) 10 mg tab fluticasone propionate (FLON
Penicillins-Hives
N/A